Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours. - Wikidata - wikimedia - TriplyDB

Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.

Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.

http://www.wikidata.org/entity/Q34176288

about

MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges MicroRNA era: the importance for diagnosis and prognosis of adrenocortical tumors Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation Analysis of circulating microRNAs in adrenocortical tumors Minireview: miRomics in endocrinology: a novel approach for modeling endocrine diseases.Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.Unraveling the global microRNAome responses to ionizing radiation in human embryonic stem cells.Identification of hsa-miR-335 as a prognostic signature in gastric cancer.Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing Reference gene selection for gene expression analysis of oocytes collected from dairy cattle and buffaloes during winter and summer.Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells.Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathways.Over-expression of miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of breast cancer patients.miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.Molecular markers of adrenocortical tumors.Control of metastatic progression by microRNA regulatory networks.Molecular markers and targeted therapies for adrenocortical carcinoma.The 'omics' of adrenocortical tumours for personalized medicine.An emerging role for long non-coding RNAs in cancer metastasis MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.Adrenocortical growth and cancer.MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.The role of microRNAs in the adrenocortical carcinomas.MiRNA-139 regulates oral cancer Tca8113 cells apoptosis through Akt signaling pathway.Proteome analysis of adrenal cortical tumors.Diverse roles of miR-335 in development and progression of cancers.MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma.Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299.Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy.Regulation of Corticosteroidogenic Genes by MicroRNAs.Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study.Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis.The human adrenal cortex: growth control and disorders

P2860

Q26751780-5E284769-2ED4-4DD4-80E4-5FB578141C9E Q26772746-FEB5B931-1EB9-4D22-881E-15A963050619 Q27027738-34F672C6-924F-40A9-9DD3-30FE9AE772C6 Q28071872-8123B185-0BE6-44EF-992B-2D6711FA5939 Q28303947-F0FCC198-0F39-46FC-885F-646E67F9697C Q33635886-9CBF65E5-C872-4924-9797-FE020ED249EC Q33689057-2AFA9858-2627-4D30-92D3-4AA5805E3DEA Q34162661-33C64D81-F0D3-46F8-A84E-F337CCEE53BE Q34339643-0055C337-6CD1-404E-AD24-2B89F14E4726 Q35075782-910ABDE0-542C-4BFD-A931-8C120D76A6AD Q35133865-064631BB-CDC9-43D8-826C-C30CD0BB7578 Q35315207-E7ACC580-10EF-48E8-B913-B797A6954381 Q35357827-20C65522-9178-486B-A762-9E4EFB75DA37 Q35882196-55B3D0A0-9D45-47BD-97B9-80F2A7267C03 Q36046557-AFB39CBF-C93D-40F6-8CFE-32F2BD205DCA Q36544748-3358B0B5-FDBF-4628-B522-00C92167740E Q36970349-771C4206-FEDB-42AA-ABC7-4E6D7120C40D Q37006838-F28D58E1-4AFF-47E2-84F1-662691B43824 Q37327593-E2EA2EE0-851F-403E-9415-E61BE2528D31 Q38002782-221739AD-8E0F-43FF-A165-ECDE44E2941B Q38111225-2B401A6F-02DF-4949-851E-769A303ED88D Q38168618-A0D608E2-7F37-4F65-90C2-7AFE8A3233A0 Q38184819-1408493D-E276-4493-BFF6-8FAC2946EA19 Q38237645-D683F751-E27D-4E37-AEA3-6A7F07835B32 Q38258284-32CB9113-1954-4ED9-8850-E3B2E1EA9CE8 Q38318638-B1F787AD-6B42-4F6E-A109-4D495F1DAAEC Q38625447-A09829DC-445D-459B-A09E-DD2473C53B27 Q38670433-08252421-CD86-4586-ACD9-1FBD466FF907 Q38851313-696AA9A8-77D1-4E27-A583-0B30393F75E9 Q38888303-5BA22A70-C0E4-4D04-A90E-319312E2565C Q38975536-C92EE1D6-6013-4AAC-B6BE-299821518F27 Q39025811-97777430-2EFC-44CA-B665-A57151215F37 Q39143464-9AB69DE0-EC92-463E-948D-A5A21B89888B Q41472378-51B8A9D3-49E0-40DC-BB79-B39506C2300B Q41500537-7F8AF730-8127-4972-B222-42ACB6161325 Q44415419-6A32278E-68BE-45DC-BA72-D0EC8C197494 Q48108818-55D6463B-9101-4342-BF6F-8B173967C9A4 Q58699198-43E7DF02-90D2-43E0-8A33-DBF441BC67DA

P2860

Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.

http://www.wikidata.org/entity/Q34176288

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Differential expression of mic ...... ignant adrenocortical tumours.

@ast

Differential expression of mic ...... ignant adrenocortical tumours.

@en

Differential expression of mic ...... ignant adrenocortical tumours.

@nl

type

label

Differential expression of mic ...... ignant adrenocortical tumours.

@ast

Differential expression of mic ...... ignant adrenocortical tumours.

@en

Differential expression of mic ...... ignant adrenocortical tumours.

@nl

prefLabel

Differential expression of mic ...... ignant adrenocortical tumours.

@ast

Differential expression of mic ...... ignant adrenocortical tumours.

@en

Differential expression of mic ...... ignant adrenocortical tumours.

@nl

P1433

Q34176288-CA2D012F-F641-4953-B9B0-9EF9F53C38C2

P1476

Q34176288-92934BD6-9926-4550-807C-DD4733E1F4D8

P2093

Q34176288-017B8D08-2D03-4A8C-8AF4-F091C4978AAB

Q34176288-15F28900-F7AD-44DD-A3F7-E3A4FF043689

Q34176288-22D6524B-F5C0-4E21-B48D-3F5BF8B17383

Q34176288-335CF15E-BE4C-4EA4-B71F-60E0CC9364C5

Q34176288-B0E9E7C2-FDA3-4BD9-B371-8E9143097270

Q34176288-BE414A81-74A9-4C6D-B162-C756123F55B2

Q34176288-E71CFB0C-0637-492E-83DA-C1C01E3DFAB1

Q34176288-E827A84E-1D6C-4B95-9662-FB886601AFBA

Q34176288-F2F4F7DC-9D1A-459A-9250-5B7236CAE604

Q34176288-FE2F806E-A265-4A97-ACFF-44B03CDE0020

P2860

Q34176288-0541227F-A380-4119-A6CC-832423EA67C5

Q34176288-0D8EA6F4-A139-4B19-B989-944BFC76AEBF

Q34176288-0EA5170C-015D-4ABB-A355-4DF8E325808B

Q34176288-0FAD45A0-4D44-4A84-8CED-E562C58B3355

Q34176288-1C9C2A71-9B1B-4CEB-B0B0-FA7C6AC0BA46

Q34176288-21629327-EA22-4354-99B2-AF0332AF35FB

Q34176288-2EE17AA9-0436-4A8A-BD16-20C383A9A50A

Q34176288-351FE957-E2A2-4491-B786-74708A129D31

Q34176288-3F21E1D2-6BA9-4979-B8E5-8876110FAFC3

Q34176288-463831F3-066B-4297-806E-F0F6A75D4985

P304

Q34176288-81B391AF-147E-4404-8009-7086C91F7A1B

P31

Q34176288-F620B4D1-E5DE-4AE2-8EA8-1FE7EC67AD09

P356

Q34176288-D29EA93C-43B3-4A93-A02B-7CE09254ECD6

P407

Q34176288-28CEF9F8-937C-4FB8-915D-FDB1319D52B6

P433

Q34176288-6065098F-1539-463E-9766-23F9D6065E02

P478

Q34176288-6E18FE42-FE03-4EB0-BD5B-515DB7E6E482

P577

Q34176288-D17BF09C-F163-4932-A6C5-5A1FD67B8A42

P5875

Q34176288-A8BA0A54-F796-4D2F-8801-846EB81E8D8B

P698

Q34176288-22935D28-B194-4DC7-8FC6-7DF752535765

P921

Q34176288-5FC8E628-95A1-42D5-BA5B-DA7E5293CBA9

P932

Q34176288-50F81F2C-1AE9-474B-9BEB-DCE22800A73A

P356

JCP.2010.085621

P1433

Journal of Clinical Pathology

P1476

Differential expression of mic ...... ignant adrenocortical tumours.

@en

P2093

A C Suttorp

http://www.w3.org/2001/XMLSchema#string

E Willscher

http://www.w3.org/2001/XMLSchema#string

J Helwig

http://www.w3.org/2001/XMLSchema#string

J Seggewiss

http://www.w3.org/2001/XMLSchema#string

K J Schmitz

http://www.w3.org/2001/XMLSchema#string

K W Schmid

http://www.w3.org/2001/XMLSchema#string

K Worm

http://www.w3.org/2001/XMLSchema#string

M K Walz

http://www.w3.org/2001/XMLSchema#string

S Bertram

http://www.w3.org/2001/XMLSchema#string

S Y Sheu

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

Widespread changes in protein synthesis induced by microRNAs

MicroRNAs: genomics, biogenesis, mechanism, and function

Analyzing real-time PCR data by the comparative C(T) method

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours.

Expression profiling identifies microRNA signature in pancreatic cancer.

MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility.

P304

529-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCP.2010.085621

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51030459

http://www.w3.org/2001/XMLSchema#string

P698

21471143

http://www.w3.org/2001/XMLSchema#string

P921

P932

3099361

http://www.w3.org/2001/XMLSchema#string